Impact of physiological media on acute myeloid leukemia bioenergetics and cell proliferation
Cancer & Metabolism,
Journal Year:
2025,
Volume and Issue:
13(1)
Published: May 26, 2025
Increasing
emphasis
has
been
placed
on
improving
the
physiological
relevance
of
cell
culture
media
with
formulations
such
as
Human
Plasma-Like
Medium
(HPLM).
Given
that
shifts
in
mitochondrial
metabolism
and
nutrient
use
are
emerging
anti-cancer
targets,
present
study
sought
to
investigate
impact
formulation
bioenergetics
cancer
growth.
To
do
this,
we
used
acute
myeloid
leukemia
(AML)
cells
compared
chronic
effects
HPLM
versus
different
supraphysiological
medias.
The
AML
phenotype
was
largely
unaffected
by
exposure
either
or
medias,
establishing
key
features
mitochondria
remain
phenotypically
stable
under
diverse
conditions
proliferation
rates.
Both
culturing
slowed
proliferation.
However,
merely
identifying
supplementing
single
nutrients
were
deficient
did
not
improve
sufficient
pinpoint
actionable
fuel
preferences.
Transferring
back
native
Iscove's
Modified
Dulbecco's
(IMDM)
immediately
restored
proliferative
phenotype,
suggesting
responsiveness
entirety
environment.
Supraphysiological
medias
other
than
IMDM
all
characterized
slower
proliferation;
however,
none
associated
changes
viability,
demonstrating
medium
is
optimal
if
experimental
aim
maximal
Despite
Eagle
(DMEM)
being
similar
composition
categorized
supraphysiological,
both
DMEM
resulted
growth,
akin
what
observed
HPLM.
Altogether,
independent
unperturbed
media,
rather
specific
relevance,
influenced
complete
profile.
Language: Английский
Organoid Intelligence: Bridging Artificial Intelligence for Biological Computing and Neurological Insights
Sangeeta Ballav,
No information about this author
Amit Ranjan,
No information about this author
Shubhayan Sur
No information about this author
et al.
Biochemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 8, 2024
Brain
organoid
implications
have
opened
vast
avenues
in
the
realm
of
interdisciplinary
research,
particularly
growing
field
intelligence
(OI).
A
brain
is
a
three-dimensional
(3D),
lab-grown
structure
that
mimics
certain
aspects
human
organization
and
function.
The
integration
technology
with
computational
methods
to
enhance
understanding
behavior
predict
their
responses
various
stimuli
known
as
OI.
ability
organoids
adapt
memorize,
key
area
exploration.
OI
encapsulates
confluence
breakthroughs
stem
cell
technology,
bioengineering,
artificial
(AI).
This
chapter
delves
deep
into
myriad
potentials
OI,
encompassing
an
enhanced
cognitive
functions,
achieving
significant
biological
proficiencies.
Such
advancements
stand
offer
unique
complementarity
conventional
computing
methods.
sphere
signify
transformative
stride
towards
more
intricate
grasp
its
multifaceted
intricacies.
intersection
biology
machine
learning
rapidly
evolving
reshaping
our
life
health.
convergence
driving
numerous
areas,
including
genomics,
drug
discovery,
personalized
medicine,
synthetic
biology.
Language: Английский
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 23, 2024
Abstract
Purpose
Despite
significant
advances
in
the
treatment
paradigm
for
patients
with
metastatic
melanoma,
melanoma
brain
metastasis
(MBM)
continues
to
represent
a
challenge.
The
study
of
MBM
is
limited,
part,
by
shortcomings
existing
preclinical
models.
Surgically
eXplanted
Organoids
(SXOs)
are
ex
vivo,
three-dimensional
cultures
prepared
from
primary
tissue
samples
minimal
processing
that
recapitulate
genotypic
and
phenotypic
features
parent
tumors
grown
without
artificial
extracellular
scaffolding.
We
aimed
develop
first
matched
patient-derived
SXO
cell
line
models
investigate
responses
targeted
therapy.
Methods
SXOs
were
created
novel
protocol
incorporating
techniques
establishing
glioma
cutaneous
organoids.
A
BRAF
V600K
-mutant
BRAF-wildtype
sample
collected
directly
operating
room
downstream
experiments.
cultured
an
optimized
culture
medium
scaffold.
Concurrently,
lines
created.
Drug
screens
conducted
assess
response
lines.
Results
Organoid
growth
was
observed
within
3-4
weeks,
retained
histological
tissue,
including
pleomorphic
epithelioid
cells
abundant
cytoplasm,
large
nuclei,
focal
melanin
accumulation,
strong
SOX10
positivity.
After
sufficient
growth,
organoids
could
be
manually
parcellated
increase
number
replicates.
Matched
demonstrated
sensitivity
MEK
inhibitors.
Conclusion
Here,
we
describe
creation
scaffold-free
organoid
model
MBM.
Further
using
may
improve
translational
relevance
studies
enable
tumor
microenvironment.
Language: Английский
Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
Xiaohong Wang,
No information about this author
Jason Ostergaard,
No information about this author
Jongseok Kang
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: July 19, 2024
Acute
lymphoblastic
leukemia
(ALL)
is
the
most
common
pediatric
malignancy,
with
relapse
being
a
major
obstacle
to
successful
treatment.
Our
understanding
of
mechanisms
driving
chemotherapy
resistance
and
ultimately
in
remains
incomplete.
Herein,
we
investigate
impact
tumor
microenvironment
on
cell
drug
responses
using
human
plasma-like
media
(HPLM),
designed
mimic
physiological
conditions
more
accurately
ex
vivo
.
We
demonstrate
that
while
chemotherapeutics
maintain
an
efficacy
HPLM
comparable
standard
tissue
culture
media,
thiopurines
6-mercaptopurine
(6-MP)
6-thioguanine
(6-TG)
exhibit
significantly
reduced
potency
against
both
B-
T-
cells
HPLM.
By
merging
our
thiopurines’
mechanism
action
metabolites
supplemented
compared
proposed
subsequently
validated
hypothesis
hypoxanthine,
purine
derivative,
responsible
for
conferring
thiopurines.
Importantly,
concentration
hypoxanthine
required
levels
found
,
supporting
clinical
relevance.
findings
utility
physiologic
identifying
characterizing
by
which
can
enable
resistance.
Understanding
such
interactions
may
inform
strategies
overcome
improve
therapeutic
outcomes
leukemia.
Language: Английский
A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective
Jing Liang,
No information about this author
Peng He
No information about this author
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Sept. 18, 2024
Glioblastoma
organoids
(GBOs)
serve
as
a
powerful
and
reliable
tool
to
study
glioblastoma
stem
cells
(GSCs)
(GBM).
GBOs
can
be
derived
from
different
materials
using
methods.
To
identify
the
predominant
generation
methods
most
applications
of
GBOs,
we
searched
four
databases
(PubMed,
Embase,
Web
Science,
Wiley
Online
Laboratory)
August
2021
2023.
After
screening,
42
out
295
articles
were
included
analyzed.
in
these
generated
only
one
material,
such
tumor
tissues,
cells,
gene-edited
multifunctional
or
simultaneously
two
materials,
normal
organoids.
Methodologically,
direct
cultivation
GBM
tissues
was
commonly
used
method
generate
GBOs.
Embryonic
(ESCs)
induced
pluripotent
(iPSCs)
frequently
by
silencing
P53,
NF1,
PTEN
CRISPR/Cas9.
In
terms
applications,
tissue
had
including
molecular
mechanisms,
therapy,
culture
technique.
This
review
provides
theoretical
reference
for
selecting
an
appropriate
when
studying
GSCs
GBM.
Language: Английский
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 22, 2024
Despite
advances
in
the
treatment
paradigm
for
patients
with
metastatic
melanoma,
melanoma
brain
metastasis
(MBM)
continues
to
represent
a
significant
challenge.
The
study
of
MBM
is
limited,
part,
by
shortcomings
existing
preclinical
models.
Surgically
eXplanted
Organoids
(SXOs)
are
ex
vivo,
three-dimensional
cultures
prepared
from
primary
tissue
samples
minimal
processing
that
recapitulate
genotypic
and
phenotypic
features
parent
tumors
without
an
artificial
extracellular
scaffold.
SXOs
were
created
novel
protocol
incorporating
techniques
establishing
glioma
cutaneous
organoids.
A
BRAFV600K-mutant
BRAF-wildtype
sample
collected
directly
operating
room.
cultured
optimized
culture
medium
Concurrently,
matched
patient-derived
cell
lines
created.
Organoid
growth
was
observed
within
3–4
weeks,
retained
histological
tissue,
including
pleomorphic
epithelioid
cells
abundant
cytoplasm,
large
nuclei,
focal
melanin
accumulation,
strong
SOX10
positivity.
After
sufficient
growth,
organoids
could
be
manually
parcellated
increase
number
replicates.
Matched
demonstrated
sensitivity
BRAF
MEK
inhibitors.
Further
using
may
improve
translational
relevance
studies
enable
tumor
microenvironment.
Language: Английский